Voloridge Investment Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,559
| Closed | -$258K | – | 1778 |
|
|
2021
Q4 | $258K | Buy |
+14,559
| New | +$258K | ﹤0.01% | 1489 |
|
|
2020
Q4 | – | Sell |
-10,328
| Closed | -$164K | – | 1633 |
|
|
2020
Q3 | $164K | Sell |
10,328
-12,265
| -54% | -$195K | ﹤0.01% | 1201 |
|
|
2020
Q2 | $446K | Buy |
+22,593
| New | +$446K | 0.01% | 1059 |
|
|
2020
Q1 | – | Sell |
-11,166
| Closed | -$206K | – | 1466 |
|
|
2019
Q4 | $206K | Buy |
+11,166
| New | +$206K | ﹤0.01% | 997 |
|